Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000250822 | SCV000302833 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000250822 | SCV000330963 | benign | not specified | 2015-07-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000250822 | SCV001442692 | benign | not specified | 2020-10-16 | criteria provided, single submitter | clinical testing | Variant summary: GLA c.1000-22C>T is located at a position not widely known to affect splicing. The variant allele was found at a frequency of 0.24 in 181209 control chromosomes in the gnomAD database, including 5568 homozygotes. The observed variant frequency is approximately 48.21 fold of the estimated maximal expected allele frequency for a pathogenic variant in GLA causing Fabry Disease phenotype (0.005), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1000-22C>T in individuals affected with Fabry Disease and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Gene |
RCV000675279 | SCV001887932 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807141 | SCV002054327 | benign | Fabry disease | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000675279 | SCV005276318 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000675279 | SCV000800935 | benign | not provided | 2015-10-23 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000250822 | SCV001955237 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000250822 | SCV001973561 | benign | not specified | no assertion criteria provided | clinical testing |